Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances
Opioid receptors | Introduction | BPS/IUPHAR Guide to PHARMACOLOGY
Biased signaling by endogenous opioid peptides | PNAS
Novel Mixed NOP/Opioid Receptor Peptide Agonists | Journal of Medicinal Chemistry
Frontiers | Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
Molecular mechanism of biased signaling at the kappa opioid receptor | Nature Communications
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Interaction between opioid receptor on keratinocytes and nerve endings... | Download Scientific Diagram
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Schematic representation of dynorphin/kappa opioid receptor system... | Download Scientific Diagram
Kappa opioid receptor (KOR) modulation of dopamine in the cortex and... | Download Scientific Diagram
Opioid Agonists & Antagonists | Basicmedical Key
Opioid Receptor | kappa, mu Opioid Receptor
The Role of Opioids and Their Receptors in Urological Malignancy: A Review
IJMS | Free Full-Text | Endogenous Opioid Peptides and Alternatively Spliced Mu Opioid Receptor Seven Transmembrane Carboxyl-Terminal Variants
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Table 1 from Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. | Semantic Scholar
Neurophysiological process - Kappa-type opioid receptor in transmission of nerve impulses Pathway Map - PrimePCR | Life Science | Bio-Rad
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Molecules | Free Full-Text | Biased Opioid Ligands
IJMS | Free Full-Text | Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor
